US 11,786,740 B2
Assessment system with wand detection cable synchronizing ECG recording
Imad Libbus, St. Paul, MN (US); Scott R. Stubbs, Maple Grove, MN (US); Scott Mazar, Woodbury, MN (US); Bruce KenKnight, Maple Grove, MN (US); and Badri Amurthur, Los Gatos, CA (US)
Assigned to LIVANOVA USA, INC., Houston, TX (US)
Appl. No. 17/55,015
Filed by LivaNova USA, Inc., Houston, TX (US)
PCT Filed May 13, 2019, PCT No. PCT/US2019/031994
§ 371(c)(1), (2) Date Nov. 12, 2020,
PCT Pub. No. WO2019/222088, PCT Pub. Date Nov. 21, 2019.
Claims priority of provisional application 62/672,019, filed on May 15, 2018.
Prior Publication US 2021/0213282 A1, Jul. 15, 2021
This patent is subject to a terminal disclaimer.
Int. Cl. A61N 1/365 (2006.01); A61N 1/39 (2006.01)
CPC A61N 1/365 (2013.01) [A61N 1/39622 (2017.08)] 10 Claims
OG exemplary drawing
 
1. A method of assessing vagus nerve stimulation in congestive heart failure treatment of a subject patient, the method comprising:
detecting a delivery of a stimulation signal from an implantable neurostimulator device in the subject patient, wherein detecting the delivery of the stimulation signal is performed by a wand assembly in communication with the implantable neurostimulator device; and
synchronizing a start of a recording of an ECG response signal with the delivery of the stimulation signal delivery based upon the detection of the delivery of the stimulation signal by the wand assembly.